Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial. (2019)
Attributed to:
Adjuvant Rituximab - a potential cure for the young patient with Graves' hyperthyroidism
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-024705
PubMed Identifier: 30670519
Publication URI: http://europepmc.org/abstract/MED/30670519
Type: Journal Article/Review
Volume: 9
Parent Publication: BMJ open
Issue: 1
ISSN: 2044-6055